Search
Explore Johnson Matthey's website
Showing results 41-60 / 205
Johnson Matthey announces opening of new electron Physical Science Imaging Centre (ePSIC)
ePSIC is a world-class centre for the study of nanoscale materials and is a result of the unique collaboration between Johnson Matthey, the University of Oxford and Diamond Light Source
ExploreHessel Douma
See what Hessel Douma has to say about his time at JM and what he thinks about the company.
ExploreSheena Hindocha
See what Sheena Hindocha has to say about her time at JM and what she thinks about the company.
ExploreJohnson Matthey and Syensqo demonstrate circular recovery of critical materials from hydrogen technologies
News
ExploreJohnson Matthey acquires pharmaceutical manufacturing capacity in Scotland, UK
The 109,000 square metre site will help meet increasing demand for custom pharmaceutical services and active ingredients using enhanced manufacturing capabilities
ExploreJohnson Matthey donates space to make ventilators
News: Johnson Matthey in Royston has donated space at one its sites in order to help DHL to assemble ventilators on behalf of Ventilator Challenge UK.
ExploreHydrogen refuelling station launches at Johnson Matthey Swindon
News: ITM Power opens seventh hydrogen refuelling station at Johnson Matthey’s Swindon site on M4 corridor.
ExploreJohnson Matthey’s Perstorp, Sweden site to expand by 50% to meet increasing demand for formaldehyde
News
ExploreGroundbreaking ceremony for Johnson Matthey's new factory in Gliwice, Poland
News: We held a ceremony for our new factory in Gliwice, Poland, which is being built to manufacture modern autocatalysts.
ExploreThe future for industry will be circular
Turning waste into high-value products makes sense for the environment and the bottom line
ExploreJM Macedonia wins award at Skopje Marathon
News: 208 JM runners were collectively recognised as the most participants representing one company at the Skopje Marathon.
ExploreJohnson Matthey invests in Fine Chemicals with expanded facility in Cambridge, UK
The investment allows us to work more closely with our customers and create strong partnerships in the Pharma and Biotech industries
Explore